期刊文献+

PRETEXT术前分期在40例肝母细胞瘤手术切除中的价值分析 被引量:4

Analysis of the PRETEXT Preoperative Staging of Hepatoblastoma for Surgical Resection
下载PDF
导出
摘要 目的:分析PRETEXT术前分期系统对肝母细胞瘤手术切除的指导价值。方法:选取天津医科大学附属肿瘤医院1997年1月至2008年1月间年龄<14岁的肝母细胞瘤患者40例,均经外科手术切除,其中术前化疗32例,统计术前影像学分期与术后病理判定是否一致。结果:40例接受原发灶切除的患者,术前PRETEXT分期与术后病理判定一致28例,占70%(28/40);术前PRETEXT分期与术后病理判定不一致12例,其中超期8例,占20%(8/40),低期4例,占10%(4/40)。结论:PRETEXT术前分期提供了一个监测术前治疗效果、帮助判断患者能否手术的依据,从而体现其预后价值。 Objective: To analyze the accuracy of the PRETEXT preoperative staging and its value to guide the surgical resection of hepatoblastoma. Methods: Statistical analysis was conducted on data from 40 hepatoblastoma patients younger than 14 years who underwent tumor resection between 1997 and 2008. Preoperative chemotherapy was administered in 32 of the patients. The PRETEXT preoperative staging, modes of surgery, and the results of postoperative pathology were compared to analyze the value of the PRETEXT preoperative staging to guide surgical resection. Results: Of the 40 patients who underwent resection of the primary lesion, 28 had concordance between the PRETEXT staging and histopathology, accounting for 70% of all cases ( 28/40 ). The remaining 12 cases had inconsistencies between the preoperative staging and postoperative histopathology, in which 8 were inappropriately assigned to more advanced stages ( 20%, 8/40 ), and 4 were inappropriately assigned to less advanced stages ( 10%, 4/40 ). Conclusion: PRETEXT preoperative staging provides a basis for the preoperative prognosis, and helps in evaluating whether surgery should be conducted in patients.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第11期672-674,共3页 Chinese Journal of Clinical Oncology
关键词 术前分期 肝母细胞瘤 切除 分析 Preoperative staging Hepatoblastoma Resection Analysis
  • 相关文献

参考文献10

  • 1Leal-Leal CA,Imaz-Olguín V.Hepatoblastoma.Clinical experience at a single institution using the Siopel staging system[J].Ann Hepatol,2010,9(1):75-79.
  • 2Otte JB.Progress in the surgical treatment of malignant liver tumors in children[J].Cancer Treat Rev,2010,36(4):360-371.
  • 3徐敏,陈其民,汤静燕,潘慈.多学科协作模式诊断治疗儿童肝母细胞瘤[J].实用儿科临床杂志,2008,23(11):829-830. 被引量:5
  • 4Sasaki F.Strategy for the treatment of hepatoblastoma in children[J].Nippon Geka Gakkai Zasshi,2005,106(7):427-430.
  • 5Derek J.Roebuck,Daniel Aronson,Philippe Clapuyt et al.2005PRETEXT:a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group.Pediatric Radiology,2007,2:123-132.
  • 6郝希山,主编.肿瘤手术学[M].北京:人民卫生出版社,2009:1226-1229.
  • 7Wang LL,Filippi RZ,Zurakowski D,et al.Effects of neoadjuvant chemotherapy on hepatoblastoma:a morphologic and immunohistochemical study[J].Am J Surg Pathol,2010,34(3):287-299.
  • 8Meyers RL,Rowland JR,Krailo M,et al.Predictive power of pretreatment prognostic factors in children with hepatoblastoma:a report from the Children's Oncology Group[J].Pediatr Blood Cancer,2009,53(6):1016-1022.
  • 9Guérin F,Gauthier F,Martelli H,et al.Outcome of central hepatectomy for hepatoblastomas[J].J Pediatr Surg,2010,45(3):555-563.
  • 10Aronson DC,Schnater JM,Staalman CR,et al.Predictive value of the pretreatment extent of disease system in hepatoblastoma:results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study[J].J Clin Oncol,2005,23(6):1245-1252.

二级参考文献8

  • 1Meyers RL, Katzen Stein HM, Malogolowkin MH. Predictive value of staging systems in hepato blastoma[ J]. J Clin Oncol,2007,25 (6) :737.
  • 2Ang JP, Heath JA, Donath S, et al. Treatment outcomes for hepatoblastoma:An institution's experience over two decades [ J ]. Pediatr Surg Int, 2007,23(2) :103 -109.
  • 3Fuchs J, Rydzynski J, VonSchweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from German Cooperative Pediatric Liver Tumor Study HB 94[J]. Cancer,2002,95 ( 1 ) : 172 - 182.
  • 4D'Antige L, Vallortigara F, Cillo U, et al. Features Predicting unresectability in hepatoblastoma[ J]. Cancer,2007,110(5) :1050 -1058.
  • 5Rana AN, Qidwai A,Pritchard J, et al. Successful treatmeat of multifocal unresectable hepato blastoma with chemotherapy only [ J ]. Pediatr Hematol Oncoi,2006,23 (2) : 153 - 158.
  • 6Ortega JA, Douglass EG, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxo- rubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group[J]. J Clin Oncoi,2000,18 (14) :2665 - 2675.
  • 7Beaunoyer M, Vanatta JM, Ogihara M,et al. Outcomes of transplantation in children with primary hepatic malignancy [ J ]. Pediatr Transplant, 2007,11 (6) :655 - 660.
  • 8Otte JB, Pritehard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL - 1 and review of the world experience [ J ]. Pediatr Blood Cancer,2004,42( 1 ) :74 - 83.

共引文献4

同被引文献25

  • 1胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 2Perilongo G, Maibach R, Shafford E, et al.Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma [J].N Engl J Med, 2009,361 (17) :1662-1670.
  • 3Ang JP, Heath JA, Donath S, et al.Treatment outcomes for hepatoblas- toma: An institution's experience over two decades [J ].Pediatr Surg Int, 2007,23(2) :103 - 109.
  • 4Trobaugh-Lotrafto AD, Tomlinson GE, Finegold MJ, et al. Small cell undifferentiated variant of he patoblastoma: adverse clinical and molecular features similar to rhabdoid tumors [J]. Pediatr Blood Cancer, 2009,52(3):328-334.
  • 5De lofts M, Brugieres L , Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience[J]. Eur J Cancer, 2008,44 (4):545-550.
  • 6Kaneko A,Umaa V, Nakamura K, et al. Vitamin D receptor polymor- phism among rickets children in Mongolia [J]. J Epidemiol, 2007,17 ( 1 ):25-29.
  • 7Piaggio G, Elbourne DR, Altman DG, et al. Reporting of noninfeft- ority and equivalence randomised trials: an extension of the CON- SORT statement[J]. JAMA, 2006,295 ( 10):1152-1160.
  • 8Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma: final report of the second study of the International Society of Paediatric Oncology - SIOPEL 2 [J]. Eur J Cancer, 2004,40 (3) :411-421.
  • 9The National Lung Screening Trial Research Team. The National Lung Screening Tftal: overview and study design [J]. Radiology, 2011,258( 1 ):243-253.
  • 10Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Can- cer J Clin, 2010,60(5):277-300.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部